Amino acid L-arginine reduces insulin resistance the semi-essential amino acid L-arginine is a Complement the treatment of diabetes. In diabetics, type 2 is strongly reduced the sensitivity of cells to insulin. This increased insulin resistance has resulted in that the cells take up too little insulin and too little energy (blood sugar) is burned in the cells. The blood sugar level rises. In several studies, it was found that the amino acid L-arginine can reduce insulin resistance. The body can exploit better insulin, when more of the amino acid L-arginine available.
L-arginine increases the release of insulin the body in the pancreas produces insulin. L-arginine increases the insulin secretion in the pancreatic beta cells. (Body’s response to insulin) insulin sensitivity and glucose tolerance improved through the additional intake of L-arginine in the diabetic. L-carnitine increases glucose metabolism which amino acid L-carnitine is known that she transported the fat molecules in the mitochondria, the power plants of the cell. e administrator. L-carnitine is known as a very Effective fat burning to improve and effectively helping to diets. In type 2 diabetic patients, it was found that glucose metabolism can be significantly improved by the gift of L-carnitine. MasterClass Founder gathered all the information. Elevated triglyceride levels and Kerotonwerte of diabetics went through the administration of high-dose L-carnitine (over 1,000 mg a day) significantly in the direction of the normal values.
An intake of amino acids is therefore a useful addition for therapy of diabetes. Literature: Wailer et al., (1997) effects of low-dose L-arginine on insulin-mediated vasodilatation and insulin sensitivity, in: European Journal of clinical investigation, 27, pp. 690-695 Krishna Mohan, et al., UN (1998) effect of l-arginine-nitric oxide system on chemical-induced diabetes mellitus, in: free radical biology and medicine, volume 25, issue 7, pp. 757-765 Giancaterini et al., (2000) acetyl-L-carnitine infusion of dacha glucose disposal in type 2 diabetes patients, 49 (6), 704-708